Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Seizure risk identified with MS drug Ampyra

Filed July 25th, 2012 Laurie

Federal health officials have issued a warning about the risk of seizures developing after taking the multiple sclerosis drug Ampyra.

The drug is manufactured by Acorda Therapeutics Inc., and is designed to allow MS patients the ability to walk better while suffering from the life-threatening condition. According to a Reuters report, the Food and Drug Administration said a recent study that linked Amprya to seizures prompted its decision to issue the public safety alert.

The study found that MS patients taking Ampyra face a greater risk of suffering seizures after first taking the drug, within the first days and weeks of a new dosage. The agency recommends that patients taking Ampyra be monitored for the first year on the drug to look for signs of seizures.

The seizures among MS patients taking Ampyra were suffered by those who have never suffered a seizure before taking the drug. The agency also identified patients with “higher blood levels” of the drug were more likely to suffer a seizure while taking Ampyra. The FDA says kidney function tests should be conducted on prospective Ampyra patients.

Ampyra has only been on the U.S. market since January 2010.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!